XTL Biopharmaceuticals Ltd
XTLB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001023549
No open-market purchases or sales by XTL Biopharmaceuticals Ltd insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $20.7K in total; no superinvestor holds it.
Superinvestors holding XTLB, Q2 2026
No superinvestor reported holding XTLB in Q2 2026.